Sign In

Ivan Coulter

Experienced Entrepreneur, CEO and Director

Ivan Coulter is an experienced entrepreneur, C-level executive, board member, and innovator based in Ireland.1 He is currently the Co-Founder of Inthelia Therapeutics, a company he established in June 2020 that focuses on fighting blood-borne infections by targeting a common host target rather than a pathogen target.1

Professional Background

Coulter has an extensive career in the biopharmaceutical and healthcare industries:

Current Roles::

  • Co-Founder of Inthelia Therapeutics (since June 2020)
  • Founder & Managing Director of Eden BioPharma Limited (since January 2020)

Previous Positions::

  • Chief Technology Officer at Sublimity Therapeutics (May 2018 - September 2018)
  • Founder, CEO, and CTO of Sigmoid Pharma Limited (August 2003 - May 2018)
  • Board Member of BIM (Bord Iascaigh Mhara), the Irish State agency for sea fishing and aquaculture industries (July 2007 - August 2011)
  • General Manager at NTera Limited (April 2000 - September 2003)

Education

Coulter has a strong educational background:

  • Post-Doctoral research in Developmental Biology at Institut Curie (1996-2000)
  • MBA in Business from Cornell University (1999-2000)
  • Diploma in Corporate Governance from The Corporate Governance Institute (2020-2021)
  • CDipAF in Accountancy and Finance from ACCA (1992-1993)1

Expertise and Focus

Ivan Coulter is known for his expertise in:

  • Translating early-stage innovations into clinical development programs
  • Developing novel therapeutics, particularly in areas like inflammatory bowel disease and autoimmune conditions
  • Leveraging technology platforms for drug delivery and development1

His current work with Inthelia Therapeutics and Eden BioPharma demonstrates his ongoing commitment to innovation in healthcare and biopharmaceuticals, with a particular focus on developing high-value products that have the potential to improve patients' lives.1

Highlights

Jan 6 · linkedin

Eddie was an inspirational entrepreneur and friend to entrepreneurs. Though very saddened by his untimely passing, I am eternally grateful for the many chats I had with him in NovaUCD. One of the last led to a discussion about Andres Iniesta, the Spanish soccer magician who said “If you win without sacrifice you enjoy it but it's more satisfying when you have struggled.” Sometimes in business as in sport, to achieve one’s goals a new team is required. Eddie’s story is a reminder that if the team doesn’t exist, don’t be afraid to build it. My sympathy to Eddie’s family, friends and colleagues. Keep his dream alive and realise it.

Dec 2 · linkedin

Nuclear future or a future unclear? This article in The Currency reminded me of the fact that Ireland’s longer term risk of over-emphasis on wind power is akin to its dependence on foreign direct investment (FDI). The direction and strength of prevailing wind is variable. Future energy independence will benefit from a grown up discussion about the green and obvious benefits of nuclear. Long term job and economic security will benefit from the right balance of FDI and indigenous enterprises. It’s time to be clear about nuclear and an energy-efficient and long-term effective economy; the alternative may be a future unclear.

#cop28 #irelandbusiness #greenenergy #eamonryan #enterpriseireland

Related Questions

What are Ivan Coulter's main achievements at Inthelia Therapeutics?
How did Ivan Coulter transition from Sigmoid Pharma to Eden BioPharma Limited?
What innovative projects is Ivan Coulter currently working on?
What is the focus of Eden BioPharma Limited under Ivan Coulter's leadership?
How has Ivan Coulter's experience at Institut Curie influenced his career?
Ivan Coulter
Ivan Coulter, photo 1
Ivan Coulter, photo 2
Add to my network

Location

Ireland